Search tips
Search criteria 


Logo of arqbrascardThis JournalSearchSubmit a ManuscriptArquivos Brasileiros de Cardiologia
Arq Bras Cardiol. 2017 March; 108(3): 271–275.
PMCID: PMC5389877

Aerobic Exercise and The Heart: Discussing Doses

The recent and exciting images of the 2016 Olympic and Paralympic Games in Rio will be forever imprinted in our minds. Hundreds of world, Olympic, continental and national records were conquered with a combination of discipline, resilience, competitiveness and overcoming challenges. Overcoming them in every sense - a result of thousands of hours of training that ensure exceptional aerobic performance from athletes with powerful and extremely healthy hearts.

The theme of aerobic exercise and the heart has never been so in evidence. Thus, in the perspective of this Olympic legacy, it is very appropriate to address the relation between aerobic exercise and the heart in the Brazilian Archives of Cardiology. More specifically, it is important to discuss the most suitable posology or dosage of exercise for adults in the context of primary and secondary prevention of cardiovascular diseases. Succinctly, the objective of this viewpoint to discuss and delimit the therapeutic range of the aerobic exercise dose for the heart and make suggestions about how this dose can be individualized according to certain criteria and objectives.

Preliminary considerations

Free animals have been and will always be active, with confinement or sedentary styles considered unnatural. Humankind, as it is known today, was able to set off from central regions and, through its own means of locomotion (exercise) spread across far areas of the planet. Seeking food and water, running from predators, from childhood to old age, have always been linked to exercise. Indeed, a sedentary lifestyle is very recent in the history of humankind.

Before approaching the theme of exercise and the heart, it is important to conceptualize some terms (Chart 1).1,2 Among several terms, it is worth highlighting the difference between physical activity and exercise. While both involve movement and/or muscle contraction with energy expenditure, in exercise there is movement intention (physical activity) in a structured and repetitive manner, with the objective of maintenance or optimization of physical conditioning and/or health and/or body aesthetics.1

Chart 1
Main concepts and terms relevant to the analysis of aerobic dose recommendations for the heart

Regarding the pharmacological dose, it can generally be defined by a therapeutic range with objective minimum and maximum limits. For a given individual, it is also possible to characterize an optimal dose with the best benefit/harm ratio. In the relation between aerobic exercise and the heart, it is also possible that there is something similar; however, to better understand this matter, we will use a few extreme examples.

From one extreme to another

In 1968, the Dallas Bed Rest Study3 analysed the cardiovascular effects of extreme inactivity. Five healthy young individuals were bedridden for 21 days, and at the end of this period, a reduction of 30% was observed in VO2max (maximum oxygen consumption), and it took them 60 days of training to recover pre-admission conditions. This 30% loss was greater then the "physiologic" reduction of aging observed in a re-evaluation done 30 years later.4

In October of 2016, two fantastic aerobic feats were accomplished. In the United States, Pete Kostelnick ran from San Francisco to New York (± 5,000 km), with an average of 110 km/day at different altitudes ( In England, Ben Smith burned over 2.5 million calories to complete 401 marathons (42.195 km) in 401 days (± 17,000 km) ( These two integrate the growing contingent of ultra-runners - > 60,000 Americans in 2013 ( - that is, those who participate in running competitions (most of which are off-road) over distances longer than marathons and, in general, more than 50 miles (80 km). These ultra-runners compose an advanced and differentiated group when compared to the more than half a million Americans who complete a marathon every year.

These two paragraphs above illustrate the extremes between the "almost zero" physical activity or exercise (bed rest) and running several hours on consecutive days for long periods of time, without even one day of rest. It objectively shows how exercise dosage is, in fact, very wide and more elastic than any cardiovascular drug, and it exemplifies the cardiac tolerance of certain individuals to enormous doses of aerobic exercise.

Discussing doses: minimum, optimal, and maximum

There is a lot of epidemiological evidence that regular aerobic exercise and high functional capacity and/or aerobic condition (VO2max) are associated to better health and longevity, while with a sedentary lifestyle, the opposite occurs.8 Indeed, the VO2max obtained (ideally through direct measure with the analysis of expired gases) in an incremental and truly maximum exercise test is an excellent health indicator9 and has recently been suggested as a vital sign.10

Even more importantly, VO2max estimates the prognosis for mortality from all causes better than any other biological marker, including glycidic/lipid profile and inflammatory markers. For example, data from Myers et al.11 indicate that, for every 1 more MET in the aerobic condition, there is a reduction of 12% in mortality from all causes; therefore, the difference in risk between two middle-age individuals with 50% and 100% of the predicted VO2max (age and gender) can be up to five times, that is, respectively, something like 1% vs 5% per year. Furthermore, in an recent example from Finland, Laukkanen et al.12 verified that, in healthy 50-year-old men, who increased their aerobic condition (direct measure) in 1 MET after 11 years of follow-up, the risk of mortality decreased by five times, when compared to those who kept their aerobic condition, and in up to 20 times, when compared to those with VO2max reduced by 4 or 5 METs in the same period. Thus, having a VO2max equal to or above the predicted (age/gender) should become a goal in the primary and secondary prevention of cardiovascular diseases.

In the characterization of the exercise dose, it is appropriate to have a unit of measurement. While there are several units proposed in literature, a very convenient one is METs-h/week, which consists of multiplying the number of exercise hours, in a given week, by the mean intensity in METs. Thus, considering that walking fast (6 km/h) and slow running (8 km/h) demand, respectively, 4 and 8 METs, we have that: if the individual completes the dose recommended in most guidelines and walks fast for 30 minutes 5x/week (150 minutes or 2 and a half hours/week) or runs slowly for 25 minutes 3x/week (total of 75 minutes or 1.25 hours/week), the exercise dose will be the same in both examples - 2.5x4 or 1.25x8 - that is, ± 10 METs-h/week.

Two articles from 2015 brought relevant contributions regarding the relation between all-cause mortality and exercise dose, considering, separately, relative volume and intensity of the exercise. Arem et al.13 identified that a maximum reduction in mortality was obtained with a dose of aerobic exercise corresponding to 3 to 5x the minimum dose recommended in the guidelines, that is, something between 20 and 50 METs-h/week (running 2 to 5 hours per week at 10 km/h) and that even a very high dose of 75-100 METs-h/week (8 to 12 hours of running per week) maintained the benefits of mortality reduction. Yet Gebel et al.14 showed that, for a given weekly duration of exercise, benefits were greater when, in at least 30% of the duration, aerobic exercise was of high intensity. In fact, these two important facts can be conflated towards the definition of an optimum dose, and also characterize what could be denominated as extreme exerciser; that is, the one that exceeds 100 METs-h/week for long periods of time, which is still scarcely found in literature. We can then initially propose that the therapeutic range of aerobic exercise dose is between approximately 7.5 to 100 METs-h/week.

In our opinion, the issue of aerobic exercise dose should be individualized according to objectives to be reached. The only known way to increase VO2 max, regardless of the current level, is by incrementing the dose of aerobic exercise. Therefore, if there is a clinical objective of increasing VO2max to reduce future mortality rate, or for the individual's sport goal, we can define the optimum dose as the one capable of offering the desired gains within a pre-established period. On the other hand, if the objective is only to maintain an excellent VO2max (> 120% of the predicted for age and gender), the optimum aerobic exercise dose may be one that is able to ensure the maintenance of this privileged aerobic condition, according to cyclical adjustments recommended by the science of physical training. Chart 2 presents recommendations of aerobic dose and periodicity of re-evaluations, considering a classification founded on the % of the predicted VO2max obtained through assessment and based on the current exercise pattern.

Chart 2
Aerobic exercise dose recommendations for adults based on: predicted %VO2max obtained in the evaluation, and current exercise pattern

Exercise exaggeration?

In 1899, Williams & Arnold15 did a thorough medical evaluation of Boston Marathon runners before the competition and one hour after completion (first place time of completion = 2h54m). They concluded that participation in the marathon did not seem to cause significant damage to the cardiovascular system of those young and healthy individuals. After more than 110 years of this rich description, there is a lot of positive evidence of athletes' and exercisers' cardiac health, such as the observation that athletes who participate in longer sporting competitions16 and physically active adults tend to live longer,17 and there is also the fact that deaths are extremely rare in half-marathons and marathons, with a rate under 1/100,000 participants.18 In this context, it is worth mentioning the case of Alexandre Ribeiro, six-time Ultraman champion, who, at 47 years of age, had accumulated 50,000 hours of aerobic training, in a typical dose of 250 METs-h/week. After extensive cardiologic, functional and image evaluation, the only finding worth commenting on was a discreet increase in the left atrium in the MRI.19

On the other hand, there are data from observational studies suggesting that there seems to be an increased risk of developing atrial fibrillation,20 of having coronary artery calcification, and presenting late enhancement or other abnormalities in cardiac imaging exams.21 However, to our best current knowledge, the clinical significance of these "abnormal" findings is still unknown.18 In this context, further studies involving large samples of ultra-runners and/or individuals who have been exercisers for over 40 years may contribute to a better understanding of the real cause-effect relation between exercise dose and benefit or harm and/or unfavorable cardiac outcomes.21 The fact is that it is currently known that very low doses of aerobic exercise bring benefits, while the maximum limit of the therapeutic dose of aerobic exercise is still unknown. That is, from a medical perspective, there is no evidence that founds a hypothesis of exercise exaggeration.22

Contextualizing in terms of public healthcare

Recent global data suggest that around 5 million deaths per year (almost 10% of total non-violent deaths) are caused by sedentary lifestyles. Moreover, it is estimated that annual worldwide costs due to low levels of physical activity/exercise surpass 67 billion dollars.23 In Brazil, government data indicate that tens of millions of Brazilians - almost half the adult population - do not exercise enough. At another extreme, it is estimated that, including athletes and exercisers, much less than 10,000 individuals do intense aerobic training regularly and for periods longer than 10 hours per week or 100 METs-h/week. That is, for every one "extreme" exerciser, there are approximately 5,000 to 10,000 sedentary individuals. It is then clear that the question of a rare and unlikely theoretical excess of exercise for the heart is not a priority in terms of public healthcare.

Therefore, a priority for cardiologists must be the reduction or elimination of the sedentary lifestyle and stimulation of an increase in the exercise dose of the population in general, thus obtaining an improvement in the aerobic condition, and, consequently, a higher life expectancy with the additional bonus of a wide range of beneficial physiological effects. On the other hand, in the case of those rare "extreme" exercisers, we can suggest that they be monitored by qualified professionals when dealing with health and training issues pertinent to this performance profile, while new evidence is gathered on the results of this "extreme" dose of aerobic exercise and its effect on the heart through the future analysis of a cohort made up of 1,200 ultra-runners.24


Author contributions

Conception and design of the research, Writing of the manuscript and Critical revision of the manuscript for intellectual content: Araújo CGS, Castro CLB, Franca JF, Souza e Silva CG.

Potential Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Sources of Funding

This study was partially funded by CNPq and FAPERJ.

Study Association

This study is not associated with any thesis or dissertation work.


1. Araújo CG. Componentes aeróbico e não-aeróbicos da aptidão física: fatores de risco para mortalidade por todas as causas. Revista Factores Risco. 2015;35(1-3):36–42.
2. Araujo CG, Scharhag J. Athlete: a working definition for medical and health sciences research. Scand J Med Sci Sports. 2016;26(1):4–7. [PubMed]
3. Saltin B, Blomqvist G, Mitchell JH, Johnson RL, Jr, Wildenthal K, Chapman CB. Response to exercise after bed rest and after training. Circulation. 1968;38(5) Suppl:VII1–VI78. [PubMed]
4. McGuire DK, Levine BD, Williamson JW, Snell PG, Blomqvist CG, Saltin B, et al. A 30-year follow-up of the Dallas Bedrest and Training Study: I. Effect of age on the cardiovascular response to exercise. Circulation. 2001;104(12):1350–1357. [PubMed]
5. Petes's Feet Across America. [2016 Nov 10]. internet. Available from:
6. The 401 challenge. [2016 Nov 10]. internet. Available from:
8. Blair SN. Physical inactivity: the biggest public health problem of the 21st century. Br J Sports Med. 2009;43(1):1–2. [PubMed]
9. Araújo CG, Herdy AH, Stein R. Maximum oxygen consumption measurement: valuable biological marker in health and in sickness. Arq Bras Cardiol. 2013;100(4):e51–e53. [PubMed]
10. Despres JP. Physical activity, sedentary behaviours, and cardiovascular health: when will cardiorespiratory fitness become a yital sign? Can J Cardiol. 2016;32(4):505–513. [PubMed]
11. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346(11):793–801. [PubMed]
12. Laukkanen JA, Zaccardi F, Khan H, Kurl S, Jae SY, Rauramaa R. Long-term change in cardiorespiratory fitness and all-cause mortality: apopulation-based follow-up study. Mayo Clin Proc. 2016;91(9):1183–1188. [PubMed]
13. Arem H, Moore SC, Patel A, Hartge P, Berrington de Gonzalez A, Visvanathan K, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015;175(6):959–967. [PMC free article] [PubMed]
14. Gebel K, Ding D, Chey T, Stamatakis E, Brown WJ, Bauman AE. Effect of moderate to vigorous physical activity on all-cause mortality in middle-aged and older Australians. JAMA Intern Med. 2015;175(6):970–977. [PubMed]
15. Williams H, Armold HD. The effects of violent and prolonged muscular exercise upon the heart. Trans Amer Clin Climatol. 1899;15:267–285. [PubMed]
16. Ruiz JR, Fiuza-Luces C, Garatachea N, Lucia A. Reduced mortality in former elite endurance athletes. Int J Sports Physiol Perform. 2014;9(6):1046–1049. [PubMed]
17. Paffenbarger RS, Jr, Hyde RT, Wing AL, Hsieh CC. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med. 1986;314(10):605–613. [PubMed]
18. Kim JH, Malhotra R, Chiampas G, d'Hemecourt P, Troyanos C, Cianca J, et al. Race Associated Cardiac Arrest Event Registry (RACER) Study Group Cardiac arrest during long-distance running races. N Engl J Med. 2012;366(2):130–140. [PubMed]
19. de Araujo CG, Belém L, Gottlieb I. A six-time Ultraman winner and a normal heart: a case report. SAGE Open Medical Case Reports. 2014;2:2050313X14522439–2050313X14522439. [PMC free article] [PubMed]
20. Sorokin AV, Araujo CGS, Zweibel S, Thompson PD. Atrial fibrillation in endurance-trained athletes. Brit J Sports Med. 2011;45(3):185–188. [PubMed]
21. La Gerche A, Baggish AL, Knuuti J, Prior DL, Sharma S, Heidbuchel H, et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging. 2013;6(9):993–1007. [PubMed]
22. Eijsvogels TM, George KP, Thompson PD. Cardiovascular benefits and risks across the physical activity continuum. Curr Opin Cardiol. 2016;31(5):566–571. [PubMed]
23. Ding D, Lawson KD, Kolbe-Alexander TL, Finkelstein EA, Katzmarzyk PT, van Mechelen W, et al. Physical Activity Series 2 Executive Committee The economic burden of physical inactivity: a global analysis of major non-communicable diseases. Lancet. 2016;388(10051):1311–1324. [PubMed]
24. Hoffman MD, Krishnan E. Health and exercise-related medical issues among 1,212 ultramarathon runners: baseline findings from the Ultrarunners Longitudinal TRAcking (ULTRA) Study. PLoS One. 2014;9(1):e83867 [PMC free article] [PubMed]

Articles from Arquivos Brasileiros de Cardiologia are provided here courtesy of Arquivos Brasileiros de Cardiologia